Magnesium L-Threonate (Magtein): The Brain-Specific Magnesium (2026 Evidence Review)

Key Takeaways

MgT came out of rat research showing that raising brain magnesium improved learning and memory and increased synapse density (Slutsky et al., 2010). Three human trials report cognitive gains: in young adults with poor sleep (Lopresti et al., 2025), in adults aged 50 to 70 with cognitive impairment (Liu et al., 2016) and, using a combination formula, in healthy Chinese adults (Zhang et al., 2022). Sleep data are split, and a trial in breast cancer survivors found no benefit at all (Ni et al., 2023). For sleep, muscle cramps or a general deficiency, magnesium glycinate is the more practical choice. Watch your total: supplemental magnesium should stay at or under 350 mg a day (NIH ODS).

What is magnesium L-threonate?

MgT is magnesium bound to L-threonate, a metabolite of vitamin C. Researchers at MIT developed it because ordinary magnesium given by mouth did little for learning and memory in their animal work, while MgT raised brain magnesium and improved both (Slutsky et al., 2010; Sun et al., 2016).

The branded form most trials used is Magtein. That matters, because results from Magtein trials cannot be assumed for every product labeled "magnesium threonate."

Threonate is a large molecule relative to magnesium, so a gram of MgT supplies much less elemental magnesium than a gram of glycinate or citrate. That makes MgT a poor tool for correcting a general shortfall, and it is why MgT and glycinate, oxide and citrate fill different roles.

How does magnesium threonate work in the brain?

In rats, raising brain magnesium with MgT improved learning, working memory and short- and long-term memory, increased synapse density in the hippocampus and boosted NMDA-receptor signaling (Slutsky et al., 2010). Later work found that threonate itself raises magnesium inside neurons, an effect other common magnesium salts did not reproduce (Sun et al., 2016).

The follow-up study added three details. Threonate occurs naturally in cerebrospinal fluid, and oral MgT raised its level there. In cultured hippocampal neurons, threonate increased intracellular magnesium, NR2B-containing NMDA receptors and functional synapse density. Those effects ran through glucose transporters, and threonate also increased synapse density in neurons derived from human stem cells (Sun et al., 2016).

In a mouse model of Alzheimer's disease, raising brain magnesium prevented synapse loss and reversed cognitive deficits (Li et al., 2014). Mouse models of Alzheimer's have a poor record of predicting human results, so this is a reason to study MgT, not proof that it treats dementia.

Two rodent studies also link higher brain magnesium to better fear extinction and less fear overgeneralization, processes relevant to anxiety (Abumaria et al., 2011; Abumaria et al., 2013). No human anxiety trial of MgT alone has been published.

What do the human trials show?

Cognition is the stronger story, with three positive trials. Sleep results differ between the two trials that measured it. One trial in a clinical population found no benefit on any outcome.

Cognitive performance and memory

The Lopresti trial randomized 100 adults aged 18 to 45 with self-reported dissatisfied sleep to 2 g of Magtein daily or placebo for 6 weeks. Overall cognition on the NIH Toolbox improved more with Magtein (p = 0.043), with the biggest effects on working and episodic memory. Reaction time improved (p = 0.031), and estimated cognitive age fell by 7.5 years. Raven's matrices, a reasoning test, did not change (Lopresti et al., 2025).

An earlier trial enrolled 44 adults aged 50 to 70 with cognitive impairment and gave them MMFS-01, a magnesium L-threonate formula, or placebo for 12 weeks. Overall cognitive ability improved significantly (p = 0.003, Cohen's d = 0.91), and executive function, which was well below age norms at baseline, nearly normalized. Strong placebo responses meant the trial could not judge effects on sleep or anxiety (Liu et al., 2016).

A third trial gave 109 healthy Chinese adults aged 18 to 65 a Magtein formula that also contained phosphatidylserine and vitamins C and D, at 2 g a day for 30 days. Scores improved on all five parts of a standard clinical memory test, with larger gains in older participants (Zhang et al., 2022). Because the formula had several ingredients, the trial cannot isolate MgT's share.

Sleep

The Hausenblas trial gave 80 adults aged 35 to 55 with self-reported sleep problems 1 g of MgT a day or placebo for 21 days. Oura ring data showed better deep and REM sleep scores with MgT, and participants reported better mood, energy, alertness and productivity. The MgT group held steady while the placebo group declined (Hausenblas et al., 2024).

The Lopresti trial, at twice the dose and twice the length, found something different. Self-reported sleep-related impairment improved, but sleep disturbance, restorative sleep and wellbeing did not, and ring data showed no sleep differences between groups. Heart rate fell and heart rate variability rose with Magtein. Among participants with more severe sleep problems, sleep disturbance did improve (Lopresti et al., 2025).

Taken together, MgT may help how people function after poor sleep more than it changes sleep itself, with clearer effects in people whose sleep is worse to begin with. For sleep as the main goal, magnesium glycinate remains the simpler first choice.

Where MgT did not help

A trial in 109 patients after breast cancer surgery gave 48 of them MgT and 61 placebo for 12 weeks. MgT did not prevent persistent post-surgical pain, and it did not improve pain, mood, sleep or cognitive scores compared with placebo (Ni et al., 2023). Positive results in healthy or mildly impaired adults do not automatically carry over to people with a different underlying problem.

How strong are the MgT results?

Promising but thin. Each finding rests on one trial, the cognitive p-values sit close to the 0.05 cut-off, and several measured outcomes did not move. The Lopresti trial's main cognitive result was p = 0.043 and its reaction-time result p = 0.031 (Lopresti et al., 2025).

Look at what stayed flat in that trial. Raven's matrices, a test of reasoning, did not change. Ring-measured sleep did not differ between groups, and neither did restorative sleep or general wellbeing (Lopresti et al., 2025). A trial that measures many outcomes will turn up some significant ones by chance, so a cluster of borderline results needs repeating before anyone treats it as settled.

The Liu trial reported a large effect, Cohen's d of 0.91, but with 23 people on MMFS-01 and 21 on placebo (Liu et al., 2016). Small trials often overestimate effect sizes. The Zhang trial tested a formula that also contained phosphatidylserine and vitamins C and D (Zhang et al., 2022), and the Hausenblas sleep trial lasted 21 days (Hausenblas et al., 2024).

None of this means MgT does nothing. It means the honest summary is "early, consistent in direction, not yet confirmed." A convincing next step would be a larger trial in one well-defined group, such as adults over 60 with mild memory complaints, lasting at least six months, with a single pre-registered primary outcome.

Magnesium threonate vs glycinate: which should you take?

They answer different questions. MgT is for cognitive support. Magnesium glycinate is for everyday magnesium needs, sleep, muscle recovery and correcting a shortfall. Most people should start with glycinate and consider MgT only if cognition is the specific goal.

Glycinate packs more elemental magnesium into each gram, is gentle on the stomach, and brings glycine along, which has calming effects of its own. Our comparison of magnesium forms covers absorption and tolerability in detail.

Taking both is possible but needs arithmetic. The NIH sets the tolerable upper intake level for magnesium from supplements and medications at 350 mg a day for adults, separate from magnesium in food (NIH ODS). Our glycinate supplies 275 mg of elemental magnesium per serving, so adding a full serving of MgT on top would push supplemental magnesium past 350 mg. Read the elemental magnesium on each label and adjust, or ask a clinician before going over the limit.

How much magnesium threonate should you take?

The trials used 1 g a day for 21 days (Hausenblas et al., 2024) and 2 g a day for 6 weeks (Lopresti et al., 2025) or 30 days (Zhang et al., 2022). No head-to-head comparison of doses exists, so the 2 g protocol behind the cognitive results is the most relevant reference point.

Splitting the daily amount between morning and evening with food is common practice and easy on the stomach. This is not a supplement you feel on day one. The cognitive changes were measured by standardized tests after weeks of daily use, so track something concrete, such as reaction time in a testing app or recall of a word list, over at least 6 weeks.

If you already take another magnesium product, count it. The 350 mg limit applies to all supplemental magnesium combined (NIH ODS).

Is magnesium threonate safe?

The published trials report good tolerability. The Lopresti trial found no significant adverse reactions (Lopresti et al., 2025), and the Hausenblas trial described MgT as safe and well tolerated (Hausenblas et al., 2024). Side effects, when they occur, resemble those of other magnesium forms, mainly loose stools at higher intakes.

The longest trial ran 12 weeks (Liu et al., 2016; Ni et al., 2023), so long-term safety at these doses has not been studied in controlled trials. Healthy kidneys clear excess magnesium from the body (NIH ODS), so people with kidney disease should not take magnesium supplements without medical advice. Magnesium supplements can also interact with medicines: they can reduce absorption of some antibiotics and of bisphosphonates for osteoporosis if taken too close together, and long-term use of acid-reflux drugs can lower magnesium levels (NIH ODS). Anyone on medicines that act on the brain should mention a new brain-targeted supplement to their prescriber.

Is the MgT research industry-funded?

Industry is involved in much of it. Three of the six authors of the Hausenblas sleep trial list AIDP, Inc. as their affiliation, and AIDP holds the copyright on the paper (Hausenblas et al., 2025 correction). Most trials tested branded Magtein or a related formula.

The trials themselves are randomized, double-blind and placebo-controlled, and that design limits how much sponsorship can shape the outcome. What is missing is a large trial by researchers with no commercial link, ideally lasting longer than 12 weeks and measuring outcomes such as cognitive decline over time.

Is magnesium acetyl taurate a better brain magnesium?

One rat study says it might be. A 2026 comparison of magnesium acetyl taurate and MgT in adult rats concluded that acetyl taurate gave better magnesium bioavailability and stronger neurophysiological effects (Kumar et al., 2026). No human study has compared the two.

The study used tissue magnesium as its primary endpoint and measured behavioral and biochemical outcomes alongside it. Its authors called acetyl taurate a promising neurotherapeutic candidate and suggested future work on brain-bioavailable magnesium salts combined with other neuroprotective compounds (Kumar et al., 2026). One author lists a commercial research company as an affiliation.

For a reader deciding what to buy today, the practical point is simple. MgT is the only brain-targeted magnesium form with randomized human trials (Lopresti et al., 2025; Liu et al., 2016). Acetyl taurate is an interesting rival on paper, and human trials would be needed before it could be recommended over MgT.

What does brain magnesium have to do with neurological disease?

Researchers are exploring the link, mostly in animals. A 2025 study found lower magnesium in the cerebrospinal fluid of patients with neuromyelitis optica spectrum disorder, an autoimmune condition of the brain and spinal cord, than in comparison patients (Fu et al., 2025).

The same team then gave MgT to a mouse model of the disease before inducing damage. Pretreatment reduced the loss of a key water-channel protein, immune-cell infiltration, activation of support cells, loss of myelin and neurological deficits. In cultured human brain blood-vessel cells, MgT also protected the tight-junction proteins that seal the blood-brain barrier, through a magnesium channel called TRPM7 (Fu et al., 2025).

Together with the Alzheimer's mouse work (Li et al., 2014) and the original learning studies in rats (Slutsky et al., 2010), this builds a picture in which brain magnesium matters for how the nervous system copes with stress and disease. None of it shows that taking MgT treats a neurological condition in people, and anyone with such a diagnosis should not use it as a substitute for medical care.

How common is low magnesium intake?

Common. A 2025 review estimates that about 31% of the world's population, roughly 2.4 billion people, do not meet recommended magnesium intakes, and national surveys in the US and elsewhere consistently find large shortfalls (Zhang et al., 2025).

The same review points to diets low in whole grains and vegetables, processing losses, soil depletion, aging and chronic disease as drivers (Zhang et al., 2025). Blood tests are a weak guide, because the body holds serum magnesium steady even when tissue stores run low.

This matters for MgT in a specific way. If brain magnesium affects synapses, as the animal work suggests (Slutsky et al., 2010; Sun et al., 2016), then a person can be eating "enough" by blood-test standards and still not be getting magnesium into the brain efficiently. That is the theory behind MgT. It has not been tested directly in people, because measuring brain magnesium in living humans is hard.

Who is magnesium threonate best for?

Adults who want cognitive support and already have their general magnesium needs covered. Trials have shown benefits in young adults with poor sleep and in adults aged 50 to 70 with cognitive impairment (Lopresti et al., 2025; Liu et al., 2016). Adults with no sleep or cognitive complaints have not been studied.

A sensible approach is to cover basic magnesium needs first, through food and, if needed, a glycinate supplement, then decide whether MgT is worth adding for memory and focus. If you stack them, keep supplemental magnesium within the 350 mg limit (NIH ODS).

For people building a broader brain or longevity routine, MgT sits alongside CoQ10 and NMN, which target cellular energy instead of synapses. For stress-driven cognitive problems, magnesium for anxiety and ashwagandha address the cortisol side more directly.

What we still do not know

Whether MgT raises brain magnesium in humans, whether it slows cognitive decline over years, and whether it helps people with diagnosed dementia. The evidence for crossing into the brain comes from animals and cultured neurons (Slutsky et al., 2010; Sun et al., 2016).

The cognitive gains in people are indirect evidence that something reached the brain, but they could also reflect effects elsewhere in the body or a placebo response that the trials did not fully control. The Alzheimer's mouse results (Li et al., 2014) have not been followed by a human dementia trial. The largest cognitive trial ran 6 weeks (Lopresti et al., 2025), which is short for a question about brain aging.

Frequently Asked Questions

References

1. Slutsky I, Abumaria N, Wu LJ, et al. Enhancement of learning and memory by elevating brain magnesium. Neuron. 2010;65(2):165-77.
2. Sun Q, Weinger JG, Mao F, et al. Regulation of structural and functional synapse density by L-threonate through modulation of intraneuronal magnesium concentration. Neuropharmacology. 2016;108:426-39.
3. Lopresti AL, Smith SJ. The effects of magnesium L-threonate (Magtein(®)) on cognitive performance and sleep quality in adults: a randomised, double-blind, placebo-controlled trial. Front Nutr. 2025;12:1729164.
4. Liu G, Weinger JG, Lu ZL, et al. Efficacy and Safety of MMFS-01, a Synapse Density Enhancer, for Treating Cognitive Impairment in Older Adults: A Randomized, Double-Blind, Placebo-Controlled Trial. J Alzheimers Dis. 2016;49(4):971-90.
5. Zhang C, Hu Q, Li S, et al. A Magtein(®), Magnesium L-Threonate, -Based Formula Improves Brain Cognitive Functions in Healthy Chinese Adults. Nutrients. 2022;14(24).
6. Hausenblas HA, Lynch T, Hooper S, et al. Magnesium-L-threonate improves sleep quality and daytime functioning in adults with self-reported sleep problems: A randomized controlled trial. Sleep Med X. 2024;8:100121.
7. Hausenblas HA, Lynch T, Hooper S, et al. Corrigendum/Erratum to "Magnesium-L-threonate improves sleep quality and daytime functioning in adults with self-reported sleep problems: A randomized controlled trial" [Sleep Med: X 8 (2024) 100121]. Sleep Med X. 2025;9:100141.
8. Ni Y, Deng F, Yu S, et al. A Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate the Therapeutic Effect of Magnesium-L-Threonate Supplementation for Persistent Pain After Breast Cancer Surgery. Breast Cancer (Dove Med Press). 2023;15:495-504.
9. Li W, Yu J, Liu Y, et al. Elevation of brain magnesium prevents synaptic loss and reverses cognitive deficits in Alzheimer's disease mouse model. Mol Brain. 2014;7:65.
10. Abumaria N, Yin B, Zhang L, et al. Effects of elevation of brain magnesium on fear conditioning, fear extinction, and synaptic plasticity in the infralimbic prefrontal cortex and lateral amygdala. J Neurosci. 2011;31(42):14871-81.
11. Abumaria N, Luo L, Ahn M, et al. Magnesium supplement enhances spatial-context pattern separation and prevents fear overgeneralization. Behav Pharmacol. 2013;24(4):255-63.
12. Zhang W, Zhao Y. Global Dietary Magnesium Deficiency: Prevalence, Underlying Causes, Health Consequences, and Strategic Solutions. Int J Vitam Nutr Res. 2025;95(6):46828.
13. National Institutes of Health, Office of Dietary Supplements. Magnesium fact sheet for consumers. Updated March 24, 2020.
14. Fu C, Huang L, Lian C, et al. Effects of long-term magnesium L-threonate supplementation on neuroinflammation, demyelination and blood-brain barrier integrity in mice with neuromyelitis optica spectrum disorder. Brain Res. 2025;1846:149234.
15. Kumar A, Mehan S, Gupta S, et al. Enhanced Neurophysiological Benefits of Magnesium-Acetyl-Taurate Over Magnesium-L-Threonate: A Comparative pre-clinical Study on Bioavailability, Synaptic Plasticity and Cognitive Functions. Neuromolecular Med. 2026;28(1).